Oliver Luxxe Assets’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$269K Hold
1,059
0.04% 190
2026
Q1
$259K Sell
1,059
-505
-32% -$118K 0.04% 188
2025
Q4
$324K Sell
1,564
-418
-21% -$82.7K 0.05% 174
2025
Q3
$367K Buy
1,982
+193
+11% +$33.1K 0.06% 167
2025
Q2
$273K Sell
1,789
-115
-6% -$17.7K 0.05% 170
2025
Q1
$316K Sell
1,904
-1,701
-47% -$266K 0.06% 170
2024
Q4
$554K Buy
3,605
+1,753
+95% +$272K 0.05% 186
2024
Q3
$300K Sell
1,852
-94
-5% -$15K 0.05% 170
2024
Q2
$284K Buy
1,946
+41
+2% +$6.1K 0.06% 166
2024
Q1
$301K Sell
1,905
-4
-0.2% -$637 0.06% 161
2023
Q4
$299K Sell
1,909
-113
-6% -$17.3K 0.07% 155
2023
Q3
$315K Buy
2,022
+8
+0.4% +$1.32K 0.08% 146
2023
Q2
$333K Sell
2,014
-104
-5% -$16.8K 0.08% 147
2023
Q1
$328K Sell
2,118
-20,871
-91% -$3.37M 0.09% 149
2022
Q4
$4.06M Buy
22,989
+349
+2% +$60.3K 1.13% 29
2022
Q3
$3.7M Buy
22,640
+6,953
+44% +$1.18M 1.16% 29
2022
Q2
$2.79M Buy
15,687
+325
+2% +$57.9K 0.82% 45
2022
Q1
$2.72M Buy
15,362
+18
+0.1% +$3.06K 0.69% 56
2021
Q4
$2.63M Buy
15,344
+12,953
+542% +$2.12M 0.66% 53
2021
Q3
$386K Sell
2,391
-804
-25% -$137K 0.11% 148
2021
Q2
$526K Buy
3,195
+251
+9% +$41.6K 0.14% 120
2021
Q1
$484K Buy
2,944
+1
+0% +$162 0.15% 122
2020
Q4
$469K Sell
2,943
-59
-2% -$8.71K 0.15% 123
2020
Q3
$447K Hold
3,002
0.17% 115
2020
Q2
$422K Hold
3,002
0.22% 90
2020
Q1
$430K Sell
3,002
-28,040
-90% -$3.98M 0.27% 85
2019
Q4
$4.53M Sell
31,042
-189
-0.6% -$25.6K 2.36% 4
2019
Q3
$4.1M Buy
31,231
+7,929
+34% +$1.04M 2.39% 4
2019
Q2
$3.29M Sell
23,302
-64
-0.3% -$8.86K 1.82% 13
2019
Q1
$3.27M Sell
23,366
-5,734
-20% -$768K 1.89% 12
2018
Q4
$3.75M Sell
29,100
-2,573
-8% -$359K 2.53% 3
2018
Q3
$4.41M Sell
31,673
-2,774
-8% -$369K 2.5% 4
2018
Q2
$4.41M Hold
34,447
2.8% 5
2018
Q1
$4.41M Buy
34,447
+19,821
+136% +$2.68M 2.73% 5
2017
Q4
$2.04M Sell
14,626
-1,642
-10% -$229K 1.24% 35
2017
Q3
$2.12M Sell
16,268
-1,270
-7% -$168K 1.33% 34
2017
Q2
$2.32M Buy
17,538
+1,972
+13% +$252K 1.51% 31
2017
Q1
$1.94M Buy
15,566
+464
+3% +$55.4K 1.29% 34
2016
Q4
$1.74M Buy
15,102
+451
+3% +$52.1K 1.2% 37
2016
Q3
$1.73M Buy
14,651
+512
+4% +$62.1K 1.36% 31
2016
Q2
$1.72M Sell
14,139
-1,074
-7% -$122K 1.46% 30
2016
Q1
$1.65M Buy
15,213
+233
+2% +$24.1K 1.69% 26
2015
Q4
$1.56M Buy
+14,980
New +$1.51M 1.4% 25

Other funds holding JNJ

Oliver Luxxe Assets's JNJ Position: Q2 2026 in Review

Oliver Luxxe Assets held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 1,059 shares worth $269K. The position accounts for 0.04% of the portfolio, ranked #190.

Oliver Luxxe Assets first reported a position in JNJ in Q4 2015 and has held it in 43 quarters since. The position peaked at $4.53M in Q4 2019. 899 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Oliver Luxxe Assets held 1,059 shares of Johnson & Johnson worth $269K as of Q2 2026.
  • Oliver Luxxe Assets left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.04% of Oliver Luxxe Assets's portfolio in Q2 2026, its #190 holding.
  • Oliver Luxxe Assets first reported a position in Johnson & Johnson in Q4 2015 and has held it in 43 quarters since.
  • Oliver Luxxe Assets's Johnson & Johnson position peaked at $4.53M in Q4 2019.
  • 899 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Oliver Luxxe Assets's 13F filing for Q2 2026, filed 9 Jul 2026.